ITMCTR2100004376招募中1 期
Research on key generic technologies and application of community prevention and control of chronic diseases related to phlegm and blood stasis
Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 40 至 80（—）
- 性别
- All
入选标准
- •1. Aged >= 40 and <= 80, male or female;
- •2. The diagnostic criteria for unstable angina pectoris were confirmed by the researchers in the Guidelines for Rapid Emergency Diagnosis and Treatment of Acute Coronary Syndrome (2019) published by the Chinese Medical Doctor Association Emergency Physicians Branch in 2019;
- •3. Global Registry of Acute Coronary Events (GRACE) risk score 2.0(18) in-hospital models; the patients will be judged as low-risk or medium-risk patients (GRACE score <140) by the researchers;
- •4. According to the main symptoms in the Diagnosing Items of Heat Retention Blood Vessel Syndrome of Coronary Heart Disease developed by our research group, the patients were judged by the researchers to be the patients with hot crunch;
- •5. Signed the informed consent and volunteered to participate in the study.
排除标准
- •1. Congenital organic heart disease, severe myocardial disease and severe cardiopulmonary dysfunction;
- •2. Severe arrhythmias (rapid atrial fibrillation, atrial flutter, paroxysmal ventricular tachycardia, etc.) with haemodynamic changes;
- •3. Complicated with severe liver dysfunction (alanine transaminase [ALT] or aspartate transaminase [AST] > 2 times the upper limit of the normal value), kidney dysfunction (creatinine > upper limit of the normal value), severe blood disease, or other serious diseases affecting survival;
- •4. Poor hypertension control (systolic blood pressure >= 160 mmHg and/or diastolic blood pressure >= 100 mmHg);
- •5. Patients with high bleeding risk, including patients with congenital bleeding diseases (such as haemophilia) or thrombocytopenia (platelet count less than 30 x 10^9/L), patients with platelet dysfunction, or patients with coagulation disorders;
- •6. Severe cognitive impairment or mental disorder, inability to complete the informed consent, inability to cooperate with the clinical treatments and evaluations;
- •7. Pregnant or lactating women or patients who intend to have children during the study period;
- •8. Current or past participation in other clinical trials (within the last three months);
- •9. Patients who need to take Chinese herbal medicine with the following ingredients: Gansui (Euphorbia kansui T. N. Liou ex T. R Wang), Jingdaji (Euphorbia pekinensis Rupr.), Haizao (Sargassum Pallidum (Turn.) C. Ag. Or Sargassum fusiforme (Harv.) Setch.), Yuanhua (Daphne genkwa Sieb.et Zucc.) and Lilu (Veratrum nigrum L.) during the treatment period;
- •10. Unsuitable for inclusion for other reasons as determined by the researcher.
研究者
相似试验
招募中
1 期
The efficacy and safety of HJ11 granules for NSTEMI(Heat Retention Blood Vessel Syndrome): a clinical exploratory trialSTEMIITMCTR2100004863Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences
招募中
1 期
The efficacy and safety of HJ11 granules for Arteriosclerosis obliterans (Heat Retention Blood Vessel Syndrome): a clinical exploratory trialITMCTR2100004381Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences
尚未招募
1 期
Research and application of key technologies in the prevention and treatment of respiratory allergic diseases with the application of acupoint sticking therapy in summer (bronchial asthma)bronchial asthmaITMCTR2100005014The First Affiliated Hospital of Zhejiang Chinese Medical University
尚未招募
1 期
Research and application of key technologies in the prevention and treatment of respiratory allergic diseases with the application of acupoint sticking therapy in summer(allergic rhinitis)allergic rhinitisITMCTR2100005033The First Affiliated Hospital of Zhejiang Chinese Medical University
招募中
1 期
Research for key technology and applications for catheter ablation of ventricular arrhythmias guided by noninvasive three-dimensional electrocardiographic mappingventricular arrhythmiasITMCTR1900002554First Affiliated Hospital of Zhejiang Chinese Medical University